Radiotherapy Patient Education with Virtual Reality
Launched by UNIVERSITY OF MIAMI · Jul 11, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) experiences can help reduce anxiety and improve the overall experience for patients undergoing radiotherapy for cancer. Researchers want to see if using VR makes patients feel less anxious compared to just watching a regular informational video. The study will compare different VR techniques to find the best ways to support patients during their treatment.
To be eligible for the study, participants must be at least 18 years old, have a confirmed cancer diagnosis, and be able to speak and read in English or Spanish. They should also be currently receiving radiotherapy at the University of Miami. During the trial, participants can expect to engage with VR experiences or watch informational videos and complete some surveys about their feelings. This research aims to make the treatment process more comfortable for patients, and it could lead to better ways to support those going through radiotherapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Histologically proven cancer
- • 2. ≥18 years of age
- • 3. Able to speak and read English and/or Spanish
- • 4. Receiving radiotherapy at the University of Miami
- Exclusion Criteria:
- • 1. Prior radiation therapy
- • 2. Pregnant or nursing women
- • 3. Men or women of childbearing potential who are unwilling to employ adequate contraception
- • 4. Patients unable to consent or are prisoners
- • 5. Participants with impaired decision-making capacity
- • 6. Any serious illness or medical condition that would compromise patient safety during virtual reality as judged by the treating physician
- • 7. Unwilling or unable to watch virtual reality video
- • 8. Unwilling to fill out survey forms
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Benjamin J Rich, MD
Principal Investigator
University of Miami
Crystal Chen, PhD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported